speb/financial-data huggingface dataset:
FATE balance_sheet (annual, 2023-12-31) — Total Capitalization: 368417000.00
FATE balance_sheet (annual, 2023-12-31) — Total Debt: 103536000.00
FATE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 368417000.00
FATE income_statement (annual, 2023-12-31) — Total Expenses: 254044000.00
FATE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 137800000.00
FATE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 174677000.00
FATE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 98706000.00
FATE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -190511000.00
FATE income_statement (annual, 2023-12-31) — Total Unusual Items: 2515000.00
FATE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 2515000.00
FATE balance_sheet (annual, 2023-12-31) — Working Capital: 292446000.00
FATE cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 942000.00
FATE cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
FATE cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
FATE income_statement (annual, 2024-12-31) — +Operating Expense: 209170000.00
FATE income_statement (annual, 2024-12-31) — +Total Revenue: 13631000.00
FATE balance_sheet (annual, 2024-12-31) — Accounts Payable: 9365000.00
FATE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3539000.00
FATE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -35136000.00
FATE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -35136000.00
FATE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1716335000.00
FATE cash_flow (annual, 2024-12-31) — Amortization Of Securities: -9080000.00
FATE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 14737000.00
FATE balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 27657000.00
FATE balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 27657000.00
FATE income_statement (annual, 2024-12-31) — Basic Average Shares: 113685177.00
FATE income_statement (annual, 2024-12-31) — Basic EPS: -1.64
FATE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 57047000.00
FATE balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 105993000.00
FATE balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 105993000.00
FATE cash_flow (annual, 2024-12-31) — Capital Expenditure: -730000.00
FATE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 85265000.00
FATE balance_sheet (annual, 2024-12-31) — Capital Stock: 117000.00
FATE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 36056000.00
FATE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 279068000.00
FATE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 99892000.00
FATE cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3130000.00
FATE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 12218000.00
FATE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -122874000.00
FATE cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -4421000.00
FATE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -1661000.00
FATE cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 5237000.00
FATE cash_flow (annual, 2024-12-31) — Change In Receivables: -1113000.00
FATE cash_flow (annual, 2024-12-31) — Change In Working Capital: -1958000.00
FATE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1113000.00
FATE cash_flow (annual, 2024-12-31) — Changes In Cash: -10764000.00
FATE balance_sheet (annual, 2024-12-31) — Common Stock: 114000.00
FATE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 318723000.00
FATE cash_flow (annual, 2024-12-31) — Common Stock Issuance: 74531000.00
FATE cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
FATE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 21348000.00
FATE balance_sheet (annual, 2024-12-31) — Current Assets: 291909000.00
FATE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 7416000.00
FATE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 7416000.00
FATE balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 393000.00
FATE balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 393000.00
FATE balance_sheet (annual, 2024-12-31) — Current Liabilities: 38522000.00
FATE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 18962000.00
FATE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 18962000.00
FATE balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 527000.00
FATE income_statement (annual, 2024-12-31) — Diluted Average Shares: 113685177.00
FATE income_statement (annual, 2024-12-31) — Diluted EPS: -1.64
FATE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -186262000.00
FATE income_statement (annual, 2024-12-31) — EBIT: -195539000.00
FATE income_statement (annual, 2024-12-31) — EBITDA: -176577000.00
FATE cash_flow (annual, 2024-12-31) — End Cash Position: 46283000.00
FATE cash_flow (annual, 2024-12-31) — Financing Cash Flow: 99892000.00
FATE cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 3130000.00
FATE cash_flow (annual, 2024-12-31) — Free Cash Flow: -123604000.00
FATE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 942000.00
FATE cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
FATE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 819000.00
FATE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 268000.00
FATE income_statement (annual, 2024-12-31) — General And Administrative Expense: 74169000.00
FATE balance_sheet (annual, 2024-12-31) — Gross PPE: 146028000.00
FATE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 14737000.00
FATE income_statement (annual, 2024-12-31) — Interest Income: 17288000.00
FATE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 17288000.00
FATE balance_sheet (annual, 2024-12-31) — Invested Capital: 318723000.00
FATE cash_flow (annual, 2024-12-31) — Investing Cash Flow: 12218000.00
FATE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 27657000.00
FATE balance_sheet (annual, 2024-12-31) — Investments And Advances: 27657000.00
FATE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 74531000.00
FATE cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
FATE balance_sheet (annual, 2024-12-31) — Leases: 59485000.00
FATE balance_sheet (quarterly, 2024-12-31) — Leases: 59485000.00
FATE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 77849000.00
FATE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 77849000.00
FATE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 4140000.00
FATE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 4140000.00
FATE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 74531000.00
FATE cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
FATE income_statement (annual, 2024-12-31) — Net Income: -186262000.00
FATE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -186262000.00
FATE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -186262000.00
FATE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -186262000.00
FATE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -186262000.00
FATE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -186262000.00
FATE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -186262000.00
FATE income_statement (annual, 2024-12-31) — Net Interest Income: 17288000.00
FATE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 12948000.00
FATE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 17288000.00
FATE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 5070000.00
FATE cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 3130000.00
FATE balance_sheet (annual, 2024-12-31) — Net PPE: 110892000.00
FATE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -730000.00
FATE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 318726000.00
FATE income_statement (annual, 2024-12-31) — Normalized EBITDA: -162659000.00
FATE income_statement (annual, 2024-12-31) — Normalized Income: -172344000.00
FATE cash_flow (annual, 2024-12-31) — Operating Cash Flow: -122874000.00
FATE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 942000.00
FATE cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
FATE income_statement (annual, 2024-12-31) — Operating Income: -195539000.00
FATE income_statement (annual, 2024-12-31) — Operating Revenue: 13631000.00
FATE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 113928279.00
FATE balance_sheet (annual, 2024-12-31) — Other Current Assets: 9302000.00
FATE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 268000.00
FATE income_statement (annual, 2024-12-31) — Other Gand A: 74169000.00
FATE income_statement (annual, 2024-12-31) — Other Income Expense: -8011000.00
FATE cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1711000.00
FATE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 10236000.00
FATE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 5070000.00
FATE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 5907000.00
FATE balance_sheet (annual, 2024-12-31) — Other Properties: 35895000.00
FATE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 243012000.00
FATE balance_sheet (annual, 2024-12-31) — Payables: 9365000.00
FATE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 30713000.00
FATE balance_sheet (annual, 2024-12-31) — Preferred Stock: 3000.00
FATE balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 3000.00
FATE income_statement (annual, 2024-12-31) — Pretax Income: -186262000.00
FATE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 20291000.00
FATE cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
FATE balance_sheet (annual, 2024-12-31) — Properties: 0.00
FATE balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
FATE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -317750000.00
FATE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -730000.00
FATE balance_sheet (annual, 2024-12-31) — Receivables: 3539000.00
FATE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 18962000.00
FATE income_statement (annual, 2024-12-31) — Research And Development: 135001000.00
FATE balance_sheet (annual, 2024-12-31) — Retained Earnings: -1397994000.00
FATE cash_flow (annual, 2024-12-31) — Sale Of Investment: 330698000.00
FATE cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
FATE income_statement (annual, 2024-12-31) — Selling General And Administration: 74169000.00
FATE balance_sheet (annual, 2024-12-31) — Share Issued: 113928279.00
FATE income_statement (annual, 2024-12-31) — Special Income Charges: -14737000.00
FATE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 41496000.00
FATE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 318726000.00
FATE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 318723000.00
FATE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
FATE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
FATE balance_sheet (annual, 2024-12-31) — Total Assets: 440694000.00
FATE balance_sheet (annual, 2024-12-31) — Total Capitalization: 318726000.00
FATE balance_sheet (annual, 2024-12-31) — Total Debt: 85265000.00
FATE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 318726000.00
FATE income_statement (annual, 2024-12-31) — Total Expenses: 209170000.00
FATE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 121968000.00
FATE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 148785000.00
FATE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 83446000.00
FATE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -210276000.00
FATE income_statement (annual, 2024-12-31) — Total Unusual Items: -13918000.00
FATE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -13918000.00
FATE balance_sheet (annual, 2024-12-31) — Working Capital: 253387000.00
FATE income_statement (quarterly, 2025-03-31) — +Operating Expense: 42909000.00
FATE income_statement (quarterly, 2025-03-31) — +Total Revenue: 1629000.00
FATE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4190000.00
FATE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2406000.00
FATE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1723715000.00
FATE cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1068000.00
FATE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 32286000.00
FATE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 118375540.00
FATE income_statement (quarterly, 2025-03-31) — Basic EPS: -0.32
FATE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 46283000.00
FATE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1196000.00
FATE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 83329000.00
FATE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 118000.00
FATE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 44920000.00
FATE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 240425000.00
FATE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
FATE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 42673000.00
FATE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -33809000.00
FATE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -606000.00
FATE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -9826000.00
FATE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 3925000.00
FATE cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1134000.00
FATE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -5373000.00
FATE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1134000.00
FATE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 8864000.00
FATE balance_sheet (quarterly, 2025-03-31) — Common Stock: 115000.00
FATE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 288406000.00
FATE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
FATE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 17213000.00
FATE balance_sheet (quarterly, 2025-03-31) — Current Assets: 248217000.00
FATE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6544000.00
FATE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6544000.00
FATE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 212000.00
FATE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 212000.00
FATE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 28159000.00
FATE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3333000.00
FATE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3333000.00
FATE balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 247000.00
FATE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 118375540.00
FATE income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.32
FATE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -37621000.00
FATE income_statement (quarterly, 2025-03-31) — EBIT: -41280000.00
FATE income_statement (quarterly, 2025-03-31) — EBITDA: -37947000.00
FATE cash_flow (quarterly, 2025-03-31) — End Cash Position: 55147000.00
FATE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
FATE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -35005000.00
FATE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 191000.00
FATE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 13773000.00
FATE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 107940000.00
FATE income_statement (quarterly, 2025-03-31) — Interest Income: 3336000.00
FATE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3336000.00
FATE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 288406000.00
FATE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 42673000.00
FATE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 32286000.00
FATE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 32286000.00
FATE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
FATE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 76785000.00
FATE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 76785000.00
FATE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
FATE income_statement (quarterly, 2025-03-31) — Net Income: -37621000.00
FATE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -37621000.00
FATE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -37621000.00
FATE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -37621000.00
FATE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -37621000.00
FATE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -37621000.00
FATE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -37621000.00
FATE income_statement (quarterly, 2025-03-31) — Net Interest Income: 3336000.00
FATE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 43869000.00
FATE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3336000.00
FATE balance_sheet (quarterly, 2025-03-31) — Net PPE: 107940000.00
FATE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1196000.00
FATE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 288409000.00
FATE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -37947000.00
FATE income_statement (quarterly, 2025-03-31) — Normalized Income: -37621000.00
FATE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -33809000.00
FATE income_statement (quarterly, 2025-03-31) — Operating Income: -41280000.00
FATE income_statement (quarterly, 2025-03-31) — Operating Revenue: 1629000.00
FATE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 114603910.00
FATE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5386000.00
FATE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 191000.00
FATE income_statement (quarterly, 2025-03-31) — Other Gand A: 13773000.00
FATE income_statement (quarterly, 2025-03-31) — Other Income Expense: 323000.00
FATE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -461000.00
FATE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 10227000.00
FATE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 5070000.00
FATE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 323000.00
FATE balance_sheet (quarterly, 2025-03-31) — Other Properties: 107940000.00
FATE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 195505000.00
FATE balance_sheet (quarterly, 2025-03-31) — Payables: 4190000.00
FATE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 21403000.00
FATE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 3000.00
FATE balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 3000.00
FATE income_statement (quarterly, 2025-03-31) — Pretax Income: -37621000.00
FATE cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
FATE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -48624000.00
FATE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1196000.00
FATE balance_sheet (quarterly, 2025-03-31) — Receivables: 2406000.00
FATE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3333000.00
FATE income_statement (quarterly, 2025-03-31) — Research And Development: 29136000.00
FATE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1435615000.00
FATE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 92493000.00
FATE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 13773000.00
FATE balance_sheet (quarterly, 2025-03-31) — Share Issued: 114603910.00
FATE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7381000.00
FATE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 288409000.00
FATE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 288406000.00
FATE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
FATE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
FATE balance_sheet (quarterly, 2025-03-31) — Total Assets: 398670000.00
FATE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 288409000.00
FATE balance_sheet (quarterly, 2025-03-31) — Total Debt: 83329000.00
FATE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 288409000.00
FATE income_statement (quarterly, 2025-03-31) — Total Expenses: 42909000.00
FATE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 110261000.00
FATE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 150453000.00
FATE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 82102000.00
FATE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -41280000.00
FATE balance_sheet (quarterly, 2025-03-31) — Working Capital: 220058000.00
FATE income_statement (quarterly, 2025-06-30) — +Operating Expense: 38875000.00
FATE income_statement (quarterly, 2025-06-30) — +Total Revenue: 1907000.00
FATE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4040000.00
FATE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1395000.00
FATE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1730869000.00
FATE cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -847000.00
FATE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 26097000.00
FATE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 118528046.00
FATE income_statement (quarterly, 2025-06-30) — Basic EPS: -0.29
FATE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 55147000.00
FATE balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 43814000.00
FATE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1362000.00
FATE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 81331000.00
FATE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 118000.00
FATE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 41249000.00
FATE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 222830000.00
FATE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1325000.00
FATE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 19591000.00
FATE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -24587000.00
FATE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -635000.00
FATE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 484000.00
FATE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -786000.00
FATE cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1010000.00
FATE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 73000.00
FATE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1010000.00
FATE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3671000.00
FATE balance_sheet (quarterly, 2025-06-30) — Common Stock: 115000.00
FATE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 261361000.00
FATE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
FATE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 18182000.00
FATE balance_sheet (quarterly, 2025-06-30) — Current Assets: 230397000.00
FATE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 5656000.00
FATE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5656000.00
FATE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 0.00
FATE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 0.00
FATE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 28673000.00
FATE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3278000.00
FATE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3278000.00
FATE balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 320000.00
FATE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 118528046.00
FATE income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.29
FATE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -34070000.00
FATE income_statement (quarterly, 2025-06-30) — EBIT: -36968000.00
FATE income_statement (quarterly, 2025-06-30) — EBITDA: -33690000.00
FATE cash_flow (quarterly, 2025-06-30) — End Cash Position: 51476000.00
FATE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1325000.00
FATE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -25949000.00
FATE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 62000.00
FATE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 11445000.00
FATE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 104911000.00
FATE income_statement (quarterly, 2025-06-30) — Interest Income: 2921000.00
FATE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2921000.00
FATE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 261361000.00
FATE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 19591000.00
FATE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 26097000.00
FATE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 26097000.00
FATE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
FATE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 75675000.00
FATE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 75675000.00
FATE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
FATE income_statement (quarterly, 2025-06-30) — Net Income: -34070000.00
FATE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -34070000.00
FATE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -34070000.00
FATE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -34070000.00
FATE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -34070000.00
FATE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -34070000.00
FATE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -34070000.00
FATE income_statement (quarterly, 2025-06-30) — Net Interest Income: 2921000.00
FATE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 20831000.00
FATE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2921000.00
FATE balance_sheet (quarterly, 2025-06-30) — Net PPE: 104911000.00
FATE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1240000.00
FATE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 261364000.00
FATE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -33690000.00
FATE income_statement (quarterly, 2025-06-30) — Normalized Income: -34070000.00
FATE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -24587000.00
FATE income_statement (quarterly, 2025-06-30) — Operating Income: -36968000.00
FATE income_statement (quarterly, 2025-06-30) — Operating Revenue: 1907000.00
FATE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 114603910.00
FATE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 6172000.00
FATE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 795000.00
FATE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 62000.00
FATE income_statement (quarterly, 2025-06-30) — Other Gand A: 11445000.00
FATE income_statement (quarterly, 2025-06-30) — Other Income Expense: -23000.00
FATE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -139000.00
FATE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 10227000.00
FATE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 5600000.00
FATE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -23000.00
FATE balance_sheet (quarterly, 2025-06-30) — Other Properties: 61097000.00
FATE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 181581000.00
FATE balance_sheet (quarterly, 2025-06-30) — Payables: 4040000.00
FATE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 22222000.00
FATE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 3000.00
FATE balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 3000.00
FATE income_statement (quarterly, 2025-06-30) — Pretax Income: -34070000.00
FATE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
FATE balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
FATE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -50813000.00
FATE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1362000.00
FATE balance_sheet (quarterly, 2025-06-30) — Receivables: 1395000.00
FATE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3278000.00
FATE income_statement (quarterly, 2025-06-30) — Research And Development: 27430000.00
FATE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1469685000.00
FATE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 71644000.00
FATE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 11445000.00
FATE balance_sheet (quarterly, 2025-06-30) — Share Issued: 114655067.00
FATE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7154000.00
FATE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 261364000.00
FATE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 261361000.00
FATE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
FATE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
FATE balance_sheet (quarterly, 2025-06-30) — Total Assets: 371632000.00
FATE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 261364000.00
FATE balance_sheet (quarterly, 2025-06-30) — Total Debt: 81331000.00
FATE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 261364000.00
FATE income_statement (quarterly, 2025-06-30) — Total Expenses: 38875000.00
FATE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 110268000.00
FATE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 141235000.00
FATE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 81595000.00
FATE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -36968000.00
FATE balance_sheet (quarterly, 2025-06-30) — Working Capital: 201724000.00
FATE income_statement (quarterly, 2025-09-30) — +Operating Expense: 36476000.00
FATE income_statement (quarterly, 2025-09-30) — +Total Revenue: 1741000.00
FATE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3504000.00
FATE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 682000.00
FATE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1735730000.00
FATE cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -810000.00
FATE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 10305000.00
FATE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 118998693.00
FATE income_statement (quarterly, 2025-09-30) — Basic EPS: -0.27
FATE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 51476000.00
FATE balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 42413000.00
FATE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2203000.00
FATE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 79245000.00
FATE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 118000.00
FATE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 40622000.00
FATE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 215423000.00
FATE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2475000.00
FATE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 21272000.00
FATE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -24374000.00
FATE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -685000.00
FATE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -550000.00
FATE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1026000.00
FATE cash_flow (quarterly, 2025-09-30) — Change In Receivables: 713000.00
FATE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 504000.00
FATE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 713000.00
FATE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -627000.00
FATE balance_sheet (quarterly, 2025-09-30) — Common Stock: 115000.00
FATE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 234063000.00
FATE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
FATE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 17571000.00
FATE balance_sheet (quarterly, 2025-09-30) — Current Assets: 221251000.00
FATE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 4751000.00
FATE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4751000.00
FATE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 5000.00
FATE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 5000.00
FATE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 28111000.00
FATE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3227000.00
FATE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3227000.00
FATE balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 410000.00
FATE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 118998693.00
FATE income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.27
FATE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -32250000.00
FATE income_statement (quarterly, 2025-09-30) — EBIT: -34735000.00
FATE income_statement (quarterly, 2025-09-30) — EBITDA: -31508000.00
FATE cash_flow (quarterly, 2025-09-30) — End Cash Position: 50849000.00
FATE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2475000.00
FATE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -26577000.00
FATE cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
FATE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 153000.00
FATE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10638000.00
FATE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 101888000.00
FATE income_statement (quarterly, 2025-09-30) — Interest Income: 2575000.00
FATE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2575000.00
FATE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 234063000.00
FATE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 21272000.00
FATE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 10305000.00
FATE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 10305000.00
FATE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
FATE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 74494000.00
FATE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 74494000.00
FATE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
FATE income_statement (quarterly, 2025-09-30) — Net Income: -32250000.00
FATE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -32250000.00
FATE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -32250000.00
FATE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -32250000.00
FATE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -32250000.00
FATE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -32250000.00
FATE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -32250000.00
FATE income_statement (quarterly, 2025-09-30) — Net Interest Income: 2575000.00
FATE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 23472000.00
FATE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2575000.00
FATE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 2475000.00
FATE balance_sheet (quarterly, 2025-09-30) — Net PPE: 101888000.00
FATE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2200000.00
FATE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 234066000.00
FATE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -31508000.00
FATE income_statement (quarterly, 2025-09-30) — Normalized Income: -32250000.00
FATE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -24374000.00
FATE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
FATE income_statement (quarterly, 2025-09-30) — Operating Income: -34735000.00
FATE income_statement (quarterly, 2025-09-30) — Operating Revenue: 1741000.00
FATE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 115336697.00
FATE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5146000.00
FATE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2280000.00
FATE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 153000.00
FATE income_statement (quarterly, 2025-09-30) — Other Gand A: 10638000.00
FATE income_statement (quarterly, 2025-09-30) — Other Income Expense: -90000.00
FATE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 94000.00
FATE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 10227000.00
FATE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 6590000.00
FATE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -90000.00
FATE balance_sheet (quarterly, 2025-09-30) — Other Properties: 59475000.00
FATE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 174801000.00
FATE balance_sheet (quarterly, 2025-09-30) — Payables: 3504000.00
FATE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 21075000.00
FATE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 3000.00
FATE balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 3000.00
FATE income_statement (quarterly, 2025-09-30) — Pretax Income: -32250000.00
FATE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
FATE balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
FATE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -57975000.00
FATE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2203000.00
FATE balance_sheet (quarterly, 2025-09-30) — Receivables: 682000.00
FATE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3227000.00
FATE income_statement (quarterly, 2025-09-30) — Research And Development: 25838000.00
FATE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1501935000.00
FATE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 81447000.00
FATE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 3000.00
FATE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10638000.00
FATE balance_sheet (quarterly, 2025-09-30) — Share Issued: 115336697.00
FATE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 4861000.00
FATE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 234066000.00
FATE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 234063000.00
FATE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
FATE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
FATE balance_sheet (quarterly, 2025-09-30) — Total Assets: 343671000.00
FATE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 234066000.00
FATE balance_sheet (quarterly, 2025-09-30) — Total Debt: 79245000.00
FATE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 234066000.00
FATE income_statement (quarterly, 2025-09-30) — Total Expenses: 36476000.00
FATE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 109605000.00
FATE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 122420000.00
FATE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 81494000.00
FATE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -34735000.00
FATE balance_sheet (quarterly, 2025-09-30) — Working Capital: 193140000.00
FATE income_statement (annual, 2025-12-31) — +Operating Expense: 154350000.00
FATE income_statement (quarterly, 2025-12-31) — +Operating Expense: 36090000.00
FATE income_statement (annual, 2025-12-31) — +Total Revenue: 6646000.00
FATE income_statement (quarterly, 2025-12-31) — +Total Revenue: 1369000.00
FATE balance_sheet (annual, 2025-12-31) — Accounts Payable: 2656000.00
FATE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2656000.00
FATE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 916000.00
FATE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 916000.00
FATE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -36223000.00
FATE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -36223000.00
FATE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1741259000.00
FATE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1741259000.00
FATE cash_flow (annual, 2025-12-31) — Amortization Of Securities: -3606000.00
FATE cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -881000.00
FATE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
FATE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 1472000.00
FATE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1472000.00
FATE income_statement (annual, 2025-12-31) — Basic Average Shares: 118789974.00
FATE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 119245759.00
FATE income_statement (annual, 2025-12-31) — Basic EPS: -1.15
FATE income_statement (quarterly, 2025-12-31) — Basic EPS: -0.27
FATE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 46283000.00
FATE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 50849000.00
FATE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 103964000.00
FATE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 103964000.00
FATE cash_flow (annual, 2025-12-31) — Capital Expenditure: -5953000.00
FATE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1192000.00
FATE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 77849000.00
FATE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 77849000.00
FATE balance_sheet (annual, 2025-12-31) — Capital Stock: 118000.00
FATE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 118000.00
FATE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 46628000.00
FATE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 46628000.00
FATE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 203657000.00
FATE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 203657000.00
FATE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5490000.00
FATE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1690000.00
FATE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 111166000.00
FATE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 27630000.00
FATE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -106084000.00
FATE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -23314000.00
FATE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -2517000.00
FATE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -591000.00
FATE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -9027000.00
FATE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 865000.00
FATE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 5179000.00
FATE cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 1014000.00
FATE cash_flow (annual, 2025-12-31) — Change In Receivables: 2624000.00
FATE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -233000.00
FATE cash_flow (annual, 2025-12-31) — Change In Working Capital: -3741000.00
FATE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1055000.00
FATE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 2624000.00
FATE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -233000.00
FATE cash_flow (annual, 2025-12-31) — Changes In Cash: 10572000.00
FATE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 6006000.00
FATE balance_sheet (annual, 2025-12-31) — Common Stock: 115000.00
FATE balance_sheet (quarterly, 2025-12-31) — Common Stock: 115000.00
FATE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 207181000.00
FATE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 207181000.00
FATE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
FATE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
FATE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 20024000.00
FATE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 20024000.00
FATE balance_sheet (annual, 2025-12-31) — Current Assets: 208704000.00
FATE balance_sheet (quarterly, 2025-12-31) — Current Assets: 208704000.00
FATE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 4562000.00
FATE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 4562000.00
FATE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4562000.00
FATE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4562000.00
FATE balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 381000.00
FATE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 381000.00
FATE balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 381000.00
FATE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 381000.00
FATE balance_sheet (annual, 2025-12-31) — Current Liabilities: 36071000.00
FATE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 36071000.00
FATE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 12901000.00
FATE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3063000.00